ARS Pharmaceuticals, Inc.
SPRY$1.09B
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSAN DIEGO162 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 12, 2026
7wMarket Overview
Stock performance and key metrics
SPRY News
Catalyst Timeline
1 upcoming, 1 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ARS-1 | Phase 2 | Asthma | - | - |
0.5 mg epinephrine | Phase 2 | Urticaria Chronic | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply